Abstract
Purpose:
This study was conducted to investigate changes in intraocular pressure (IOP) in the presence of intravitreal gas bubbles in individuals who travel through subsea tunnels.
Methods:
Using a mathematical model, we simulated alterations in ocular globe shape, aqueous humor flow, volume of intravitreal gas bubbles, and IOP due to elevation changes during travel through subsea tunnels. We simulated five tunnels with different features as case studies. The role of key modeling parameters was further evaluated in a parametric study.
Results:
In three out of the five simulated tunnels (i.e., Seikan Tunnel, Bomlafjord Tunnel, and the Atlantic Ocean Tunnel), the patients were potentially at risk at lower portions of the tunnels since the IOP dropped to values less than 5 mm Hg, the clinical threshold for ocular hypotony. During ascent, the IOP increased to the normal value of 15 mm Hg and in some cases to higher values (e.g., a peak value of 22 mm Hg in Seikan Tunnel).
Conclusions:
Our model predicted that in the presence of intravitreal gas bubbles, the IOP could drop to extremely low values when patients descend to lower elevations in some tunnels. Such low IOP values could cause bleeding and/or retinal detachment. Since many factors (e.g., tunnel specifications and/or patient-specific characteristics) could affect the IOP during subsea travel, caution (beyond avoiding airplane flights) should be taken in advising patients about travel restrictions following intravitreal gas injections.
Translational Relevance:
Our findings highlight the potential risk for hypotony in the presence of intravitreal gas bubbles during subsea travels.
Previously, it has been shown that exposure to high altitudes could lead to dangerously high values of IOP in patients with intravitreal gas bubbles,
5,7,14 an observation that was confirmed by our theoretical model.
9 In this study, for the first time, we showed that injection of intravitreal gas bubbles may put patients who travel through subsea tunnels at high risk for ocular hypotony. Potential occurrence of transient ocular hypotony during travel through subsea tunnels may negatively affect the vison, which is particularly dangerous if the patient is driving. In addition, ocular hypotony may cause bleeding and/or re-detachment of the repaired retina due to the collapse of the corneoscleral shell. Although this study focuses on travel in subsea tunnels and further research is certainly necessary, we suspect that any activity that requires rapid descent to lower elevations (e.g., diving, scuba diving, ski jumping, and bungee jumping) could potentially put patients at risk for ocular hypotony.
Our model predictions of the risk of ocular hypotony greatly depended on the profiles of specific subsea tunnels. Deeper tunnels—such as the Seikan Tunnel, Bomlafjord Tunnel, and the Atlantic Ocean Tunnel, which have low elevation values of −240, −260, and −250 m, respectively—showed more extensive drops in the IOP values, which would increase the risk of hypotony at the lowest elevations. The mechanism of the IOP reduction at the lower elevations can be described as follows: during the descent, the bubble size decreases, subsequently leading to IOP reduction. Although aqueous humor outflow also drops due to its dependency on IOP as a physiological feedback mechanism to maintain normal IOP, the aqueous humor flow changes cannot entirely compensate for the drop in IOP due to the bubble size reduction. The reason for such a phenomenon is that the changes in the bubble size with elevation are instantaneous, whereas the aqueous humor feedback mechanism has a much slower pace. As shown in our parametric study, a slower descent can help prevent hypotony. Such a case can be observed in the Channel Tunnel: although it is relatively deep (the lowest elevation is −115 m), a slow descent rate of 18 m/min can allow an accumulation of the aqueous humor that is sufficient to maintain the IOP above 5 mm Hg in spite of the instantaneous reductions in bubble size.
It should be noted that the accumulation of the aqueous humor, which is needed to maintain the IOP during the descent, could be problematic. As can be seen in the case of the Seikan Tunnel, increased volume of the aqueous humor along with the bubble size expansion could lead to IOP values above the normal value of 15 mm Hg. To avoid high peak IOP values after ascending from the lowest point of the tunnel, the ascent rate should also be kept low so that the eye can compensate for the expansion of the bubble.
Our parametric study also predicted that two of the simulated tunnels, the Bomlafjord Tunnel and the Atlantic Ocean Tunnel, are the most dangerous tunnels to travel in, as compared to other tunnels simulated in this study. In particular, the risk of ocular hypotony can be eliminated only if the intravitreal gas bubble is smaller than 20% of the ocular globe volume. In all other cases for these tunnels, IOP was predicted with values less than 5 mm Hg for all simulated ranges of descent rate, aqueous humor production rate, outflow facility, and ocular compliance (
Figs. 4–
8).
It should be noted that two of the tunnels (Seikan Tunnel and Channel Tunnel) are rail tunnels that could be used for high-speed trains. The internal pressure of a high-speed train may fluctuate while traveling through a tunnel.
29 In particular, a compression/expansion wave is formed when a train enters/exits the tunnel, and the wave propagates along the tunnel at a nearly sonic speed. This pressure change depends on many factors including the length of the train, the shape of the train, the section of the train in which the patient is seated, the tunnel cross-sectional area, and how well the train car is sealed. This fluctuation in pressure could be as high as 2 kPa and may exceed the pressure changes due to the change in elevation. Such fluctuations are not included in our current model, and our predicted IOP in these tunnels may not reflect the actual IOP of passengers traveling in high-speed trains.
29
Similar to many other theoretical models, the model used in this study is not free of limitations. We have extensively discussed our model limitations in our previous publications.
9,11 Briefly, our model did not include volume changes due to ocular blood flow. Further, the nonlinearity in the ocular globe in response to IOP changes was not considered; neither were the viscoelastic effects and gas diffusion. Moreover, a fixed outflow facility was used in the model, even though it has been shown that outflow facility is altered with changes in IOP.
30,31 In our previous work,
9,11 we were confident that the abovementioned limitations did not affect our model predictions significantly because we were able to closely match the model predictions with clinically and/or experimentally measured values in a number of cases for which those data were available. Although the physical phenomena occurring during the descent portion of the travel through a subsea tunnel is similar in theory to those of our previously validated model, to our best knowledge, no measurements of IOP during travel to lower altitudes are available for case-specific validations. Future experimental measurements of IOP changes during travel to lower elevations will be extremely beneficial for further assessing the accuracy of our theoretical model predictions. Collectively, due the assumptions and simplifications, the exact IOP value predicted by this theoretical model may be different from the clinical measurements of IOP.
In summary, our simulation showed that traveling through subsea tunnels can put patients with intravitreal gas bubbles at risk for ocular hypotony. Such risk mainly depends on the change in elevation during travel, the descent rate, and the initial bubble size. Smaller changes in elevation, slower descent rates, and smaller sizes for the injected bubbles can be considered to avoid extreme IOP reductions. Although future experimental measurements could increase the level of confidence in our theoretical model, we believe that cautioning patients to avoid travel through deep subsea tunnels may be necessary to avoid ocular hypotony following the injection of intravitreal gases.